OMEGA THERAPEUTICS INC (OMGA) Stock Price, Quote, News and Overview
NASDAQ:OMGA - Nasdaq - US68217N1054 - Common Stock - Currency: USD
OMGA Quote, Performance and Key Statistics
0.1426
-0.02 (-10.82%)
The current stock price of OMGA is 0.1426 USD. In the past month the price decreased by -71.98%. In the past year, price decreased by -96.68%.
OMGA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About OMGA
Company Profile
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 93 full-time employees. The company went IPO on 2021-07-30. The Company’s OMEGA platform has enabled it to identify and validate various DNA-sequence-based epigenomic, zip codes, associated with individual regulatory elements within Insulated Genomic Domains (IGDs). The firm designs and engineers its mRNA therapeutics, called epigenomic controllers, or ECs, to target EpiZips for precision epigenomic control. Its pipeline consists of programs that span oncology, regenerative medicine, and multigenic diseases including immunologic and cardiometabolic conditions. The Company’s precision epigenomic control delivered by the OMEGA platform has therapeutic applicability and transformational potential, spanning across oncology, multigenic diseases including immunologic and cardiometabolic conditions, and regenerative medicine.
Company Info
OMEGA THERAPEUTICS INC
140 First Street, Suite 501
Cambridge MASSACHUSETTS US
CEO: Mahesh Karande
Employees: 94
Company Website: https://omegatherapeutics.com/
Investor Relations: https://ir.omegatherapeutics.com/
Phone: 16179494360
OMEGA THERAPEUTICS INC / OMGA FAQ
What is the stock price of OMEGA THERAPEUTICS INC today?
The current stock price of OMGA is 0.1426 USD. The price decreased by -10.82% in the last trading session.
What is the ticker symbol for OMEGA THERAPEUTICS INC stock?
The exchange symbol of OMEGA THERAPEUTICS INC is OMGA and it is listed on the Nasdaq exchange.
On which exchange is OMGA stock listed?
OMGA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OMEGA THERAPEUTICS INC stock?
7 analysts have analysed OMGA and the average price target is 13.26 USD. This implies a price increase of 9198.74% is expected in the next year compared to the current price of 0.1426. Check the OMEGA THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OMEGA THERAPEUTICS INC worth?
OMEGA THERAPEUTICS INC (OMGA) has a market capitalization of 7.90M USD. This makes OMGA a Nano Cap stock.
How many employees does OMEGA THERAPEUTICS INC have?
OMEGA THERAPEUTICS INC (OMGA) currently has 94 employees.
Is OMEGA THERAPEUTICS INC (OMGA) expected to grow?
The Revenue of OMEGA THERAPEUTICS INC (OMGA) is expected to grow by 233.18% in the next year. Check the estimates tab for more information on the OMGA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OMEGA THERAPEUTICS INC (OMGA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OMGA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OMGA, evaluating the profitability, health, valuation and growth aspects
- OMEGA THERAPEUTICS INC (OMGA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OMEGA THERAPEUTICS INC (OMGA) Sales and EPS estimates to see what analysts future expectations are.
- OMEGA THERAPEUTICS INC (OMGA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OMEGA THERAPEUTICS INC (OMGA) Insider and Institutional Ownership to learn about the owners and their transactions.
- OMEGA THERAPEUTICS INC (OMGA) Stock Chart to make your own analysis
- OMEGA THERAPEUTICS INC (OMGA) Latest news and press-releases to stay up to date.
Does OMEGA THERAPEUTICS INC (OMGA) stock pay dividends?
OMGA does not pay a dividend.
What is the Price/Earnings (PE) ratio of OMEGA THERAPEUTICS INC (OMGA)?
OMEGA THERAPEUTICS INC (OMGA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.33).
What is the Short Interest ratio of OMEGA THERAPEUTICS INC (OMGA) stock?
The outstanding short interest for OMEGA THERAPEUTICS INC (OMGA) is 13.58% of its float. Check the ownership tab for more information on the OMGA short interest.
OMGA Technical Analysis
OMGA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OMGA. OMGA may be in some trouble as it scores bad on both profitability and health.
OMGA Financial Highlights
Over the last trailing twelve months OMGA reported a non-GAAP Earnings per Share(EPS) of -1.33. The EPS increased by 36.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.86% | ||
| ROE | -633.21% | ||
| Debt/Equity | 1 |
OMGA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to OMGA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 34.35% and a revenue growth 233.18% for OMGA